FDA member Ross Thompson awarded Individual Impact Award 2024

FDA member Ross Thompson received the Individual Impact Award for his work increasing membership and engagement in the Northern Ireland Section, the union’s fastest growing constituency.
Ross identifies a few main elements behind the successful expansion. The first was collaborating with FDA Learn to secure funding from the Irish Congress Trade Union’s (ICTU) Learning Fund for members and to help attract potential members:
“We also put on more events to make sure people feel that they’re getting some sort of value from their subscription. Not just that there’s the reassurance that we’re there if they need us, but also that there’s things we’re doing proactively.”
Membership growth also came from the Graduate Management Programme, specific to Northern Ireland and similar to the Fast Stream, as well as word of mouth.
Ross explains:
“We have put a lot of effort into our personal cases, and at the end of every case we’d be telling people to make sure they tell their friends and colleagues about us.”
Speaking about what receiving the award meant to him , Ross says:
“I was really touched that people that see me week in, week out on calls and in the Executive Committee meetings felt that the work I do, or the effort I put in, is worthy of recognition. I was really humbled and really pleased, proud to get it.
“It’s easy to think that Northern Ireland could get left behind because a lot of what goes on in Westminster doesn’t have much of an impact as it’s a devolved administration and there’s a strong regional element. But I really felt like [General Secretary Dave Penman] saw the work that we’ve been doing and he’s pleased, and it means something to him that we have been doing so well on membership numbers.”
Ross continues:
Related News
-

“An outstanding leader with a proven track record” – FDA responds to Dame Antonia Romeo appointment
The FDA has welcomed the appointment of former Home Office Permanent Secretary Dame Antonia Romeo as Cabinet Secretary, following the departure of Sir Chris Wormald last week.
-

“New low” for government’s relationship with civil service – FDA responds following departure of Cabinet Secretary Chris Wormald
The FDA has responded to the announcement that Sir Chris Wormald has departed the role of Cabinet Secretary, with FDA General Secretary Dave Penman describing it as a “new low” for the government’s relationship with the civil service.
-

“Farcical” to wait until 2030 to make decision on restoration and renewal of parliament, says FDA
The FDA has responded to the latest publication of UK Parliament’s Restoration and Renewal Board, ‘Delivering restoration and renewal of the Palace of Westminster: the costed proposals.’